Cell Acute Lymphoblastic Leukemia
Childhood pre B cell acute lymphoblastic leukemia with translocation t(1;19)(q21 1;p13 3) and two additional chromosomal aberrations involving chromosomes 1, 6, and 13: a case report
6
Prediction of outcomes by early treatment responses in childhood T-cell acute lymphoblastic leukemia: a retrospective study in China
11
Pharmacokinetics and dose adjustment of etoposide administered in a medium-dose etoposide, cyclophosphamide and total body irradiation regimen before allogeneic hematopoietic stem cell transplantation
7
Leukemia relapse following unmanipulated haploidentical transplantation: a risk factor analysis on behalf of the ALWP of the EBMT
11
Expression of the polycomb group gene Bmi1 does not affect the prognosis of pediatric acute lymphoblastic leukemia
6
T cell senescence and CAR-T cell exhaustion in hematological malignancies
9
Stem cells in clinical practice: applications and warnings
20
A high complex karyotype involving eleven chromosomes including three novel chromosomal aberrations and monoallelic loss of TP53 in case of follicular lymphoma transformed into B-cell lymphoblastic leukemia
7
Chimeric antigen receptors for adoptive T cell therapy in acute myeloid leukemia
14
Case Report B-acute lymphoblastic leukemia occurring in two pediatric patients with a history of prior Wilms tumors
10
<p>Infectious complications in children with malignant bone tumors: a multicenter nationwide study</p>
10
The Philadelphia chromosome in leukemogenesis
15
Protein kinase inhibitors for acute leukemia
7
Emerging roles of epithelial-mesenchymal transition in hematological malignancies
8
Drugging the unfolded protein response in acute leukemias
10
Childhood leukemia: central nervous system abnormalities during and after treatment
16
VITAMIN D STATUS IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA
7
Pediatric donor cell leukemia after allogeneic hematopoietic stem cell transplantation in AML patient from related donor
7
WILMS' TUMOR GENE 1 (WT1) EXPRESSION IN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA
5
BET inhibitors in the treatment of hematologic malignancies: current insights and future prospects
11